Get the Stockscreener App
1.75
0.00%
0.00
After Hours:
1.75
Talis Biomedical Corp stock is traded at $1.75, with a volume of 6,011.
It is up +0.00% in the last 24 hours and down -54.79% over the past month.
See More
Previous Close:
$1.75
Open:
$1.81
24h Volume:
6,011
Relative Volume:
33.00
Market Cap:
$N/A
Revenue:
$368.00K
Net Income/Loss:
$-75.48M
P/E Ratio:
-0.0365
EPS:
-47.9446
Net Cash Flow:
$-56.05M
1W Performance:
+23.09%
1M Performance:
-54.79%
6M Performance:
-79.19%
1Y Performance:
-70.69%
1-Day Range:
$1.75
$1.87
1-Week Range:
$1.75
$1.87
52-Week Range:
$1.75
$1.87
Talis Biomedical Corp Stock (TLIS) Company Profile
Name
Talis Biomedical Corp
Sector
Industry
Phone
-
Address
-
Compare TLIS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| TLIS | 1.75 | 0 | 368.00K | -75.48M | -56.05M | -47.94 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Talis Biomedical Corp Stock (TLIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-27-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-31-21 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-12-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-09-21 | Initiated | BTIG Research | Buy |
| Mar-09-21 | Initiated | BofA Securities | Neutral |
| Mar-09-21 | Initiated | JP Morgan | Overweight |
| Mar-09-21 | Initiated | Piper Sandler | Overweight |
View All
Talis Biomedical Corp Stock (TLIS) Latest News
Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedi - GuruFocus.com
Baker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical Corp - Yahoo Finance
Talis Biomedical Agrees to Settle Investor Suit for $33 Million - Bloomberg Law
Biotech Investors Reach $32.5M Deal Over Failed COVID Test - Law360
Delisting of Securities of OceanTech Acquisitions I Corp.; OCA Acquisition Corp.; Assure Holdings Corp.; Selina Hospitality PLC; Maquia Capital Acquisition Corporation; ToughBuilt Industries, Inc.; SunPower Corporation; Meta Materials Inc.; Talis Biomedical - Yahoo Finance
Talis Biomedical ends Chicago office lease with $3.62 millio fee By Investing.com - Investing.com Australia
Talis Biomedical ends Chicago office lease with $3.62 millio fee - Investing.com India
Talis Biomedical executive buys $44,240 in company stock - Investing.com
Talis Biomedical executive buys $44,240 in company stock By Investing.com - Investing.com Canada
Talis Biomedical settles lawsuit with Kriya Therapeutics - Investing.com
Talis Biomedical executive buys $2,000 in stock - Investing.com India
Talis Biomedical executive buys $2,000 in stock By Investing.com - Investing.com South Africa
Talis Biomedical executive buys $641 in stock - Investing.com
Talis Biomedical executive buys $641 in stock By Investing.com - Investing.com UK
Talis Biomedical agrees to $32.5 million settlement - Investing.com
Talis Biomedical agrees to $32.5 million settlement By Investing.com - Investing.com UK
Talis Biomedical Corp [TLIS] Insider Activity: An Update for Investors - Knox Daily
Financial Metrics Exploration: Understanding Talis Biomedical Corp (TLIS) Through Ratios - The Dwinnex
Braden Michael Leonard Acquires 13,167 Shares of Talis Biomedical Co. (NASDAQ:TLIS) Stock - Defense World
Talis Biomedical executive buys shares worth over $56k By Investing.com - Investing.com Canada
Talis Biomedical executive buys shares worth over $56k - Investing.com
Talis Biomedical stock hits 52-week low at $3.71 amid market challenges - Investing.com Australia
Talis Biomedical to be delisted from Nasdaq on September 3 By Investing.com - Investing.com Australia
Talis Biomedical (NASDAQ:TLIS) Stock Quotes, Forecast and News Summary - Benzinga
Stocks to Watch: MIRA Pharmaceuticals, Talis Biomedical - MarketWatch
Talis Biomedical to be delisted from Nasdaq on September 3 - Investing.com
Talis Biomedical Shares Fall on Bankruptcy Filing, Delisting Notice - MarketWatch
Talis: Q2 Earnings Snapshot - The Advocate
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical Corporation - Marketscreener.com
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors - Marketscreener.com
Talis Biomedical stock hits 52-week low at $4.24 amid market challenges - Investing.com
Why Talis Biomedical (TLIS) Stock Is Getting Obliterated Today - Benzinga
Why Is Talis Biomedical (TLIS) Stock Down 52% Today? - MSN
Talis Biomedical Shares Tumble Premarket as Company Mulls Bankruptcy - MarketWatch
Talis Biomedical Announces Board Shake-Up Amid Financial Struggles - TipRanks
(TLIS) Proactive Strategies - Stock Traders Daily
SHAREHOLDER ALERT: Morris Kandinov Investigating GDOT, - GlobeNewswire
(TLIS) Trading Report - Stock Traders Daily
Talis Biomedical (NASDAQ:TLIS) Shares Down 0.2% - Defense World
Head-To-Head Contrast: Talis Biomedical (NASDAQ:TLIS) and Prenetics Global (NASDAQ:PRE) - Defense World
Prenetics Global (NASDAQ:PRE) vs. Talis Biomedical (NASDAQ:TLIS) Head to Head Survey - Defense World
Objective long/short (TLIS) Report - Stock Traders Daily
Talis Biomedical (NASDAQ:TLIS) & Akoya Biosciences (NASDAQ:AKYA) Financial Survey - Defense World
Talis Biomedical (NASDAQ:TLIS) Trading 2.1% Higher - Defense World
Trend Tracker for (TLIS) - Stock Traders Daily
Talis Biomedical (NASDAQ:TLIS) Shares Down 1.3% - Defense World
(TLIS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Talis Biomedical Corp Stock (TLIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
0.43%
Cap:
|
Volume (24h):